Compare Invesco DB Oil Fund (DBO) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Oil Fund vs Johnson & Johnson — how do they compare? Invesco DB Oil Fund trades at $20.98, while Johnson & Johnson trades at $260.86 (market cap $626.09B). The key difference: Johnson & Johnson pays a 2.06% dividend while Invesco DB Oil Fund pays none, and Johnson & Johnson is trading nearer its 52-week high, Invesco DB Oil Fund nearer its low. Which is the better fit depends on your goals.
| DBO | JNJ | |
|---|---|---|
Sector | Commodities - Energy | Health |
52-Week High | $23.80 | $267.24 |
52-Week Low | $11.98 | $172.78 |
Market Cap | — | $626.09B |
Volume | — | 6,156,228 |
Enterprise Value | — | $654.37B |
Dividend Yield | — | 2.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBO trades at $20.99, up 0.67% today, with a bullish technical signal from moving averages. The stock shows neutral oscillators but faces uniform support and resistance at $21. Recent news highlights oil market volatility due to Middle East tensions and OPEC demand forecast cuts, influencing energy sector sentiment.
The outlook is clouded by supply disruptions and demand uncertainty, posing risks for energy stocks. Investment appeal hinges on oil price stability and company-specific fundamentals, which require verification from recent SEC filings and earnings reports for a complete assessment.
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco DB Oil Fund
DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
